Research & Education
CURE Expert Connections
Email Sign Up
To start your customized experience click the start button
Customize your homepage by selecting specific cancer types.
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Side Effect Management
Small Lymphocytic Lymphoma (SLL)
Advocacy & Research
Share Your Story
Newsletter Sign Up
Ovarian Cancer Heroes
Bone Health Champions
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
cureTV – Empowering Patients Through Video
Regaining Intimacy After an Ovarian Cancer Diagnosis
Saketh Guntupalli, M.D.
Saketh Guntupalli, M.D., gynecologic oncologist at the University of Colorado Hospital, discusses ways that women can improve intimacy after an ovarian cancer diagnosis.
CAR T-Cell Therapy Offers Hope in DLBCL
Peter Borchmann, M.D.
CAR-T cell therapy is generating excitement for the treatment of diffuse large B-cell lymphoma, according to an update from the JULIET trial.
It's an Exciting Time for Mantle Cell Lymphoma
Michael Wang, M.D.
There are many exciting advances happening in the field of mantle cell lymphoma.
Deciding Best Next Steps in Prostate Cancer Treatment
Matthew R. Cooperberg, M.D., M.P.H.
Here's how one expert decides on the next steps in treatment when a man with prostate cancer has a rising PSA and no visible metastases.
Overcoming Barriers and Stigma as a Young Patient
Taylor Bell Duck
Taylor Bell Duck was only 21 when she was diagnosed with lung cancer, a disease that is often stigmatized.
Prostate Cancer: To Treat or Not to Treat
Howard Soule, Ph.D.
We've come a long way in determining which patients with prostate cancer to treat, but there is still more work that needs to be done.
Exploring Another Biomarker in Ovarian Cancer
David O'Malley, M.D.
Folate receptor alpha was a promising biomarker when it came to treatment with mirvetuximab soravtansine.
Colorectal Cancer Makeup May Differ by Age Group
Aaron Franke, M.D.
Recent research found that patients under 50 were less likely to have a treatment-determining biomarker than their older counterparts.
Comparing Two MPN Drugs
Trine Alma Knudsen, M.D.
An expert discusses a trial comparing recombinant interferon alpha-2 with hydroxyurea in patients with myeloproliferative neoplasms (MPNs).
When Facing Metastatic Prostate Cancer, Know What to Ask Your Doctor
There are some key discussions that men with metastatic prostate cancer should have with their health care providers.
Not a member?
Sign up now!
Continue without login
OPTIONAL INFORMATION: The following information helps us tailor CURE to fit your needs
Please type below what best describes your interests and click on the selection(s):
I am a:
Please list other: